SB 3
Referred to committee
Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.
- Michigan
- Senate
- Introduced Jan 8, 2025
- Session 2025-2026
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Michigan’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
17 actions-
referred to Committee on Government Operations
-
read a first time
-
received on 04/24/2025
-
PASSED ROLL CALL # 68 YEAS 20 NAYS 15 EXCUSED 1 NOT VOTING 1
-
AMENDMENT(S) ADOPTED
-
AMENDMENT(S) DEFEATED
-
PLACED ON IMMEDIATE PASSAGE
-
RULES SUSPENDED
-
PLACED ON ORDER OF THIRD READING WITH SUBSTITUTE (S-1)
-
SUBSTITUTE (S-1) CONCURRED IN
-
REPORTED BY COMMITTEE OF THE WHOLE FAVORABLY WITH SUBSTITUTE (S-1)
-
RULES SUSPENDED FOR IMMEDIATE CONSIDERATION
-
REFERRED TO COMMITTEE OF THE WHOLE WITH SUBSTITUTE (S-1)
-
REPORTED FAVORABLY WITH SUBSTITUTE (S-1) 4/23/2025
-
SENATE CO-SPONSOR(S) NAMED: STEPHANIE CHANG
-
REFERRED TO COMMITTEE ON FINANCE, INSURANCE, AND CONSUMER PROTECTION
-
INTRODUCED BY SENATOR DARRIN CAMILLERI